Evaluating the Pharmacokinetic Characteristics of AD-102 in Healthy Volunteers

• Status: Completed
• Trial end date: 2019-04-08
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of this study is to evaluate the pharmacokinetic characteristics of AD-102 in healthy male subjects

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Addpharma Inc.
• Treatments: Cholecalciferol; Raloxifene Hydrochloride

Criteria

Inclusion Criteria:

• Body mass index (BMI) between 17.5 kg/m2 and 30.5 kg/m2 at the time of screening visit

• The Age between 19 and 50 in healthy male volunteers at the time of screening visit

Exclusion Criteria:

• As a result of laboratory tests, the following figures: ALT or AST> 2 times upper limit of normal range

• As a result of laboratory tests, the following figures: 25-OH vitamin D total <9 ng/mL